Effects of Different Dosing and Feeding Intervals on the Pharmacokinetic Parameters of Herombopag Olamine Tablets
Phase of Trial: Phase I
Latest Information Update: 13 Aug 2018
At a glance
- Drugs Hetrombopag (Primary)
- Indications Idiopathic thrombocytopenic purpura
- Focus Adverse reactions; Registrational
- Sponsors Jiangsu Hengrui Medicine Co.
- 01 Aug 2018 Status changed from not yet recruiting to recruiting.
- 31 Jul 2018 New trial record